Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbachol and brimonidine eye drops for presbyopia
ACTRN12616001565437Phase 3Completed
- Sponsor
- Almamoun Abdelkader
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of carbachol and brimonidine in presbyopia (4 arms), sponsored by Almamoun Abdelkader. Primary endpoint: Near visual acuity. Started Feb 2016; status: completed.
02
Drugs
carbacholbrimonidine
03
Conditions
presbyopia
Beyond the preview
Go deeper on ACTRN12616001565437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001565437.